This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Abelacimab
  • /
  • Safety and Tolerability of Abelacimab (MAA868) vs....
Clinical trial

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation (AZALEA-TIMI 71)

Read time: 1 mins
Last updated:18th Apr 2021
Status: Recruiting
Identifier: NCT04755283
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest